Main Session
Sep
30
SS 43 - Lung 5: Locally Advanced NSCLC: PORT and Cardiac Toxicity
346 - Differential Survival Benefits of PORT in AJCC-9th /IASLC-Defined N2 NSCLC Substages: A Multicenter Real-World Study
Presenter(s)
Yongxing Bao, MD - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS & PUMC, Beijing, Beijing